News Release

National Academies advisory: genes and toxic chemicals

Peer-Reviewed Publication

National Academies of Sciences, Engineering, and Medicine

Research is increasingly revealing how toxic chemicals disrupt gene activity and other cell processes in ways that lead to health problems -- and why some individuals are particularly vulnerable. For example, studies suggest that genetic variations make some people more likely to experience side effects from certain medications, such as some cancer treatments and blood thinners.

How can this type of research -- known as toxicogenomic research-- best be applied to protect public health, and that of individuals? APPLICATIONS OF TOXICOGENOMIC TECHNOLOGIES TO PREDICTIVE TOXICOLOGY AND RISK ASSESSMENT, a new report from the National Research Council, examines future applications and benefits of this research, and recommends ways government agencies and others can move the field forward. It also explores the ethical and social issues raised by toxicogenomic methods -- such as how to protect the privacy of individuals' genetic information.

###

Reporters can obtain copies by contacting the National Academies' Office of News and Public Information at 202-334-2138 or e-mailing news@nas.edu. Advance copies will be available to reporters only starting at noon EDT on Thursday, Oct. 4. THE REPORT IS EMBARGOED AND NOT FOR PUBLIC RELEASE BEFORE 10 A.M. EDT ON TUESDAY, OCT. 9.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.